BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24526468)

  • 1. Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression.
    Puolakkainen P; Koski A; Vainionpää S; Shen Z; Repo H; Kemppainen E; Mustonen H; Seppänen H
    Med Oncol; 2014 Mar; 31(3):884. PubMed ID: 24526468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer.
    Valkovskaya N; Kayed H; Felix K; Hartmann D; Giese NA; Osinsky SP; Friess H; Kleeff J
    J Cell Mol Med; 2007; 11(5):1162-74. PubMed ID: 17979891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol affects the growth and metastasis of pancreatic cancer via ADAM8.
    Yu X; Shi J; Wang X; Zhang F
    Pharmacol Rep; 2020 Apr; 72(2):418-426. PubMed ID: 32048249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM8 as a drug target in pancreatic cancer.
    Schlomann U; Koller G; Conrad C; Ferdous T; Golfi P; Garcia AM; Höfling S; Parsons M; Costa P; Soper R; Bossard M; Hagemann T; Roshani R; Sewald N; Ketchem RR; Moss ML; Rasmussen FH; Miller MA; Lauffenburger DA; Tuveson DA; Nimsky C; Bartsch JW
    Nat Commun; 2015 Jan; 6():6175. PubMed ID: 25629724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between pancreatic cancer cells and tumor-associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migration of macrophages.
    Meng F; Li C; Li W; Gao Z; Guo K; Song S
    IUBMB Life; 2014 Dec; 66(12):835-46. PubMed ID: 25557640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both macrophages and hypoxia play critical role in regulating invasion of gastric cancer in vitro.
    Shen Z; Kauttu T; Seppänen H; Vainionpää S; Ye Y; Wang S; Mustonen H; Puolakkainen P
    Acta Oncol; 2013 May; 52(4):852-60. PubMed ID: 23193956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.
    Hamada S; Satoh K; Fujibuchi W; Hirota M; Kanno A; Unno J; Masamune A; Kikuta K; Kume K; Shimosegawa T
    Mol Cancer Res; 2012 Jan; 10(1):3-10. PubMed ID: 22064652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.
    Cho K; Matsuda Y; Ueda J; Uchida E; Naito Z; Ishiwata T
    Int J Oncol; 2012 Apr; 40(4):1040-8. PubMed ID: 22159401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-dependent expression of ADAM8 in human pancreatic cancer cell lines.
    Valkovskaya NV
    Exp Oncol; 2008 Jun; 30(2):129-32. PubMed ID: 18566576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM8 as a novel serological and histochemical marker for lung cancer.
    Ishikawa N; Daigo Y; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
    Clin Cancer Res; 2004 Dec; 10(24):8363-70. PubMed ID: 15623614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of miR-21 and miR-211 on MMP9 regulation in pancreatic ductal adenocarcinoma: cooperation in invasiveness behaviors?
    Funel N
    Epigenomics; 2015; 7(3):333-5. PubMed ID: 26077422
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
    Chen SH; Hung WC; Wang P; Paul C; Konstantopoulos K
    Sci Rep; 2013; 3():1870. PubMed ID: 23694968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma.
    Berchtold S; Grünwald B; Krüger A; Reithmeier A; Hähl T; Cheng T; Feuchtinger A; Born D; Erkan M; Kleeff J; Esposito I
    Cancer Lett; 2015 Jan; 356(2 Pt B):721-32. PubMed ID: 25449434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propofol inhibits pancreatic cancer proliferation and metastasis by up-regulating miR-328 and down-regulating ADAM8.
    Yu X; Gao Y; Zhang F
    Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):271-278. PubMed ID: 30861616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and MMP-9.
    Cook L; Sengelmann M; Winkler B; Nagl C; Koch S; Schlomann U; Slater EP; Miller MA; von Strandmann EP; Dörsam B; Preußer C; Bartsch JW
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propofol mediates pancreatic cancer cell activity through the repression of ADAM8 via SP1.
    Gao Y; Zhou Y; Wang C; Sample KM; Yu X; Ben-David Y
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of a disintegrin and a metalloproteinase 8 (ADAM8) in osteoclastogenesis and pathological bone destruction.
    Ainola M; Li TF; Mandelin J; Hukkanen M; Choi SJ; Salo J; Konttinen YT
    Ann Rheum Dis; 2009 Mar; 68(3):427-34. PubMed ID: 18397961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer.
    Onishi H; Kai M; Odate S; Iwasaki H; Morifuji Y; Ogino T; Morisaki T; Nakashima Y; Katano M
    Cancer Sci; 2011 Jun; 102(6):1144-50. PubMed ID: 21338440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions.
    Kolb A; Kleeff J; Guweidhi A; Esposito I; Giese NA; Adwan H; Giese T; Büchler MW; Berger MR; Friess H
    Cancer Biol Ther; 2005 Jul; 4(7):740-6. PubMed ID: 15970685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.